Lifecore Biomedical, Inc. LFCR Income Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $128.87M+0.5% | $128.26M+24.2% | $103.27M-7.2% | ||
| $88.57M+2.5% | $86.41M+14.8% | $75.29M+10.4% | ||
| $40.3M-3.7% | $41.85M+49.5% | $27.99M-28.4% | ||
| 31.3%-1.4pp | 32.6%+5.5pp | 27.1%-8.0pp | ||
| $8.26M-3.7% | $8.58M-1.9% | $8.74M+12.9% | ||
| $44.86M+10.5% | $40.61M+4.2% | $38.97M+17.5% | ||
| —— | —— | -$21.8M-71.8% | ||
| —— | —— | $15.66M+9.9% | ||
| —— | -$3.05M-163% | -$1.16M-248% | ||
| -$38.67M— | —— | -$63.93M-216% | ||
| $43K— | —— | $308K+106% | ||
| -$38.72M— | —— | -$99.56M+14.7% | ||
| -30%— | —— | -96.4%+8.5pp | ||
| -$1.23— | —— | -$3.32+16.4% | ||
| -$15.66M— | —— | -$8.62M-260% | ||
| -12.2%— | —— | -8.3%-13.2pp | ||
| -$23.69M— | —— | -$21.8M-71.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Lifecore Biomedical, Inc.'s revenue?
- Lifecore Biomedical, Inc. (LFCR) generated $125.9M in revenue over the trailing twelve months, down 3.8% year over year.
- Is Lifecore Biomedical, Inc. profitable?
- Lifecore Biomedical, Inc. is not currently profitable: it reported a net loss of $40.9M over the trailing twelve months, a -30.0% net margin.
- What are Lifecore Biomedical, Inc.'s profit margins?
- Gross margin is 31.3% and operating margin is -14.5%, with a -30.0% net margin.
- What is Lifecore Biomedical, Inc.'s earnings per share?
- Lifecore Biomedical, Inc.'s diluted EPS over the trailing twelve months is $-1.17.
- Where does Lifecore Biomedical, Inc.'s income statement data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
